| 000 | 01339 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516064430.0 | ||
| 264 | 0 | _c20120416 | |
| 008 | 201204s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656566.2011.635644 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiannopoulos, Krzysztof | |
| 245 | 0 | 0 |
_aTreating chronic lymphocytic leukemia with thalidomide and lenalidomide. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cDec 2011 |
||
| 300 |
_a2857-64 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aThalidomide _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMertens, Daniel | |
| 700 | 1 | _aStilgenbauer, Stephan | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 12 _gno. 18 _gp. 2857-64 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.2011.635644 _zAvailable from publisher's website |
| 999 |
_c21325632 _d21325632 |
||